Latest Breaking News On - இன்சுலின் டெலிவரி - Page 1 : comparemela.com
Tandem Diabetes Care Announces Presentations Demonstrating Positive Real-World Improvements with Control-IQ Technology Across Diverse Populations
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Insulin Delivery Devices Market is expected to reach US$ 22,830 0 Mn with a CAGR of 8 7% from 2018-2025
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Stem Cell Therapy for Type 1 Diabetes by Jayashree on June 9, 2021 at 9:45 PM
Recently developing a promising approach for treating this condition is reported in the journal
Nature Communications by Scientists at the Salk Institute using stem cells to create insulin-producing cells (called beta cells) to replace non-functional pancreatic cells with proven results in mouse model. Stem cells are an extremely promising approach for developing many cell therapies, including better treatments for type 1 diabetes, says Salk Professor Juan Carlos Izpisua Belmonte, the paper s senior author.
‘New stem cell therapy can effective to treat type 1 diabetes.’
The investigators started with human pluripotent stem cells (hPSCs) having the potential to become any kind of cell found in the adult body coaxed into beta cells in a stepwise fashion that mimicked pancreatic development using various growth factors and chemicals resulted in about 10 to 40 percent of cel
Cell Stress Mechanisms in Liver Disease Identified by Colleen Fleiss on April 1, 2021 at 7:11 AM
A new prognostic factor for primary sclerosing cholangitis (PSC) from liver biopsies has been identified by researchers. This is so-called cellular ER stress.
Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat, since its causes have not yet been adequately researched.
PSC is a rare disease with a poor prognosis and can lead to cirrhosis of the liver or bile duct cancer. It affects 0.01% of the population but, even though it is rare, PSC is responsible for more than 10% of all liver transplants, making it the third most common indication on liver transplant waiting lists in Europe.
vimarsana © 2020. All Rights Reserved.